Market View 10th June, 2026

View on market: Volatility persists, eagerly searching for growth:

Global markets traded with a cautious tone. US and European index futures showed a mixed trend, while most Asian markets opened weak due to pressure in key regional indices. Investors remained watchful amid global uncertainties and sector-specific movements. In the US, markets ended mixed. Gains in real estate, healthcare, and utility stocks supported the broader market, but weakness in technology and energy shares weighed on overall sentiment. This led to a softer close for major growth-focused indices. Indian markets witnessed a positive trading session and recovered after recent weakness. Benchmark indices closed higher, supported by buying across sectors and improved investor confidence. Broader markets outperformed the main indices, reflecting strong participation from mid-sized companies. Several stocks from the technology and specialty chemicals space delivered notable gains and boosted overall market sentiment. Overall, Indian equities showed resilience despite mixed global cues, with broader market strength indicating continued investor interest in domestic growth opportunities.

Economic Calendar:

• USD: CPI Data on 10^th June 2026.
• IND: Inflation Rate and Foreign Reserves Data on 12^th June 2026.
• USD: Monetary Policy on 17^th June 2026.
• IND: WPI and Unemployment Rate on 15^th June 2026.

BROKERAGE RADAR:

CLSA ON SBI:

Target ₹1275 Recommendation Outperform, Stronger Priority Sector Lending compliance, focus on retail deposits are key highlights, FY26 was a good year for the bank, Corporate salary accounts grew 11% in FY26 to cross 20 million, RIDF assets, too, have been stagnant since FY24, implying a lower drag on NIM.

NUVAMA ON INDIGO:

Target ₹5335 Earlier Target ₹5054 Recommendation Accumulate, Indigo is well placed to convert near-term headwinds into opportunities, Industry PAX to be 2x by FY35E (246mn in FY26) as structural growth drivers stay intact, International segment key driver of growth, IndiGo currently has an outstanding order book of 901 airplanes.

JP MORGAN ON COLGATE PALMOLIVE:

Target ₹2250 Recommendation Neutral, Premiumization playbook intact; EBITDA margin capped by reinvestment, Positive FY27 outlook, towards balanced, premiumization led revenue growth, Oral care category should be relatively resilient amidst inflation headwinds, Urban is improving, while rural remains stable but more exposed to inflation.

DAM CAPITAL ON PHYSICS WALLAH:

Target ₹140 Recommendation Accumulate, One Indian ed-tech story where scale did not come at the P&L’s expense, Expect 24% / 71% revenue / EBITDA CAGR over FY26-28E, Only major Indian ed-tech player to approach profitability, Refusal to pay the star-teacher salaries that broke every peer.

International Markets:

U.S & Europe:

*As per 10^th June.

Asian markets:

Stocks strong on Chart:

Commodities & Currency:

FIIs & DIIs:

View on market: Volatility persists, eagerly searching for growth

News Updates:

Source: Moneycontrol, Bloomberg Quint, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited (Elite Wealth Limited is wholly owned subsidiary of InCred Capital Financial Services Limited) does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Vindhyachal Prasad, Elite Wealth Limited, vindhyachal@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

1. All of the views expressed in the report accurately reflect his or her personal views about any and all of

the subject securities or issuers; and

2. No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale. Legal

Entities Disclosures

Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

1. 1. Reports
   2. EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
   3. EWL or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
   4. EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

1. Compensation
2. EWL  or its associates have not received any compensation from the subject company in the past twelve months;
3. EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
4. EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
5. EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
6. EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research
7. In respect of Public Appearances
8. EWL or its associates have not received any compensation from the subject company in the past twelve months;
9. The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL